Skip to main content

Assessing Immunotherapy responsiveness with PET scans

Intervista a Michael A. Postow By 4 Dicembre 2023No Comments

Which role for imaging before and during cancer immunotherapy to assess Immunotherapy responsiveness? We asked Michael A. Postow (Chief Melanoma Service – Memorial Sloan Kettering Cancer Center, New York), that we met at Melanoma Bridge congress 2023 in Naples.